Treatment for anxiety and depression using NeuroGlove
Impact of Peripheral Sensory Stimulation of the Hand and Synchronized Deep Breathing in the Treatment of Anxiety and Depression: Assessing Safety and Effectiveness
This study is testing if the NeuroGlove can help people with anxiety and depression feel better while they use it at home.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | NeuroGlove LLC Industry-sponsored |
| Locations | 1 site (Minneapolis, Minnesota) |
| Trial ID | NCT06065787 on ClinicalTrials.gov |
What this trial studies
This interventional clinical study aims to evaluate the effectiveness of the NeuroGlove in treating individuals with active symptoms of anxiety and depression. A total of 10 subjects will be recruited from the community and will receive treatment in a home-based setting. Participants must be able to provide informed consent and have symptoms that significantly impact their daily lives. The study will not affect the participants' ongoing care management.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 85 with a diagnosis of anxiety and/or depression that affects their daily activities.
Not a fit: Patients with physical limitations of the upper extremity or those unable to comply with study protocols may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a novel approach to alleviating symptoms of anxiety and depression.
How similar studies have performed: While this approach is relatively novel, similar studies have shown promise in using technology for mental health treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject. * Men and women ≥18 and \<85 years of age. * Carry an active diagnosis of anxiety and/or depression. * Suffer from anxiety and/or depression symptoms that impact subject's daily activities and quality of life. Exclusion Criteria: * Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.) * The subject lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements. * Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)
Where this trial is running
Minneapolis, Minnesota
- NeuroGlove — Minneapolis, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Eric Nussbaum, MD — NeuroGlove LLC
- Study coordinator: Thomas Harold
- Email: info@neuroglove.net
- Phone: 6122550405
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.